S2EP3 How Fenbendazole And Ivermectin Could Reshape Cancer Care

About this episode

The episode explores the potential impact of fenbendazole and ivermectin on cancer treatment and challenges the current drug approval processes.

Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...

Topics covered

• cancer care
• antiparasitics
• drug approval
• cell structure
• immune signaling
• clinical trials

Keywords

• fenbendazole
• ivermectin
• cancer
• cell-cycle arrest
• apoptosis
• efflux pump
• clinical trials

Mentioned in this episode

Products: fenbendazole, ivermectin

More episodes of Fenbendazole Voices

• S2 EP9 Fenbendazole and the Immune System: What We Know So Far · January 13, 2026 · 40 min
• S2 EP7 Success Stories — What People Are Saying About Fenbendazole · January 13, 2026 · 38 min
• S2 EP8 How to Talk to Your Doctor About Off-Label Treatments · January 13, 2026 · 8 min
• S2 EP6 Can You Build a Protocol Around Fenbendazole? · January 13, 2026 · 22 min
• S2EP5 Why Independent Testing Is Your Only Real Safeguard · November 25, 2025 · 36 min
• S2EP4 What Is Fenbendazole? A Simple Guide to Its Role in Alternative Cancer Support · November 11, 2025 · 12 min